Skip to Main Content

Paper Details

Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells.
Int J Cancer
25
2019
Author NameAffiliation
Olli KallioniemiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Olli KallioniemiKarolinska Institutet
  • 1 - 2

Datasets

Release 1.2